World Cancer Meeting 2017 is designed to facilitate the dissemination and application of research findings related to cancer for International medical professionals and oncologists .It provides an opportunity to meet and communicate with leading doctors, surgeons, scientists, academic professionals from around the world and listen to top speakers about the on new developments that impact and advance the future of cancer science. It is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and thereby provides a list of new techniques.

Cancer is the second leading cause of death worldwide and in all regions of the world except sub-Saharan Africa. Historically, the UAE had a much lower incidence of cancer than Western countries; however, over the last 40 years, it has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity. The Scope of Cancer Science & Therapy Conference is to inform the scientific community about all innovative aspects regarding cancer diseases. The participants can gather knowledge about the topics like Cancer, Cell Biology, Organ Specific Cancers, and Advances in Treatment Approaches, Cancer Genetics, Anti-Cancer Therapies, Cancer Immuno science, Cancer Diagnosis, Stem Cell Therapy, Treatment trough Precision Medicine, Cancer Management and Prevention, Economic Aspects of Cancer Therapies.

With individuals from around the globe concentrated on finding out about Cancers; this is your best chance to achieve the biggest array of members from the International Cancer Societies and Associations to direct Workshops , convey data, meet with present and potential researchers, make a sprinkle with new medication advancements, and get name acknowledgment at this 2-days occasion. Incredibly famous speakers, the latest methods, improvements, and the most up to date overhauls in Gynecologic Cancers are signs of this meeting.